These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21658618)

  • 1. Treatment strategies in advanced stage follicular lymphoma.
    van Oers MH; Kersten MJ
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New agents in follicular lymphoma.
    Cheson BD
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):305-12. PubMed ID: 21658626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.
    Bachy E; Salles G
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):257-70. PubMed ID: 21658622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular engineering to improve antibodies' anti-lymphoma activity.
    Peipp M; van de Winkel JG; Valerius T
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):217-29. PubMed ID: 21658620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and treatment of follicular lymphoma.
    Piccaluga PP; Sapienza MR; Agostinelli C; Sagramoso C; Mannu C; Sabattini E; Zinzani PL; Pileri SA
    Expert Rev Hematol; 2009 Oct; 2(5):533-47. PubMed ID: 21083019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular lymphoma: emerging therapeutic strategies.
    Kenkre VP; Kahl BS
    Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
    Zinzani PL; Marchetti M; Billio A; Barosi G; Carella AM; Lazzarino M; Martelli M; Rambaldi A; Rigacci L; Tarella C; Vitolo U; Tura S;
    Am J Hematol; 2013 Mar; 88(3):185-92. PubMed ID: 23339086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preface on follicular non-Hodgkin's lymphoma.
    Hagenbeek A
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):93. PubMed ID: 21658610
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
    Seiler T; Hiddemann W; Dreyling M
    Immunotherapy; 2009 Nov; 1(6):1015-24. PubMed ID: 20635916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antibodies against follicular non-Hodgkin's lymphoma.
    van Meerten T; Hagenbeek A
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):231-56. PubMed ID: 21658621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
    Yáñez R; Barrios Y; Ruiz E; Cabrera R; Díaz-Espada F
    J Immunother; 2008 Apr; 31(3):310-2. PubMed ID: 18317357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolent lymphomas: current and emerging treatment approaches.
    Maloney D; Kahl BS; Dreyling M
    Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies in follicular lymphomas: current status and future perspectives.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
    J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
    Sacchi S; Pozzi S; Marcheselli L; Bari A; Luminari S; Angrilli F; Merli F; Vallisa D; Baldini L; Brugiatelli M;
    Cancer; 2007 May; 109(10):2077-82. PubMed ID: 17394190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive significance of the cut-off value of CD20 expression in patients with B-cell lymphoma.
    Horvat M; Kloboves Prevodnik V; Lavrencak J; Jezersek Novakovic B
    Oncol Rep; 2010 Oct; 24(4):1101-7. PubMed ID: 20811695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current immunochemotherapy strategies in follicular lymphoma.
    Giné E; Gutiérrez-García G; López-Guillermo A
    Adv Ther; 2010 Oct; 27(10):704-13. PubMed ID: 20820973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas.
    Domingo-Domènech E; González-Barca E; Estany C; Sureda A; Besalduch J; Fernández de Sevilla A
    Haematologica; 2002 Nov; 87(11):1229-30. PubMed ID: 12414357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.